NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
CC E-173-2011-0-US-01 SYSTEM AND METHOD FOR PROBABILISTIC ABLATION PLANNING US 61/414,938 Abandoned
NCI E-339-2004-0-US-07 Framework Residue Substituted Humanized Col-1 Antibodies And Their Use US DIV 12/946,381 8828717 Abandoned PDF
NCI E-091-2008-0-US-03 Method For Detection And Quantification Of Plk1 Expression and Activity US National Stage 12/992,887 Abandoned
NCI E-025-2010-0-AU-03 Diazeniumdiolated Compounds, Pharmaceutical Compositions, And Methods of Treating Cancer AU National Stage 2010319398 Issued
NICHD E-299-2009-0-PCT-02 Diagnosis and Treatment of Cancer Using Histone Deacetylase Inhibitors (HDACi) And Radiolabeled Metaiodobenzylguanidine PCT PCT PCT/US2010/056543 Abandoned
NCI E-022-2010-0-PCT-02 Modulated Programmed Death Ligand-1 PCT PCT PCT/US2010/056450 Expired
NCI E-025-2010-0-PCT-02 Diazeniumdiolated Compounds, Pharmaceutical Compositions, And Methods of Treating Cancer PCT PCT PCT/US2010/056446 Expired
NCI E-025-2011-0-US-01 Antibodies to Tumor Endothelial Marker 8 US 61/412,999 Abandoned
NCI E-022-2010-0-CA-03 Modulated Programmed Death Ligand-1 (PD-L1) CA National Stage 2780572 Abandoned
NIDCR E-015-2002-1-US-06 Mammalians Sweet And Amino Acid Heterodimeric Taste receptors Comprising T1R3 and T1R1 US CON 12/944,515 8470970 Expired PDF
NIAID E-031-2004-2-US-13 Anti-Tubercular Drug: Compositions And Methods US CON 12/944,231 8268894 Expired PDF
NCI E-174-2008-0-GB-10 SILENCING OF CSN5 GENE EXPRESSION USING INTERFERING RNA GB EP 09731523.8 Issued
NCI E-174-2008-0-DE-09 SILENCING OF CSN5 GENE EXPRESSION USING INTERFERING RNA DE EP 09731523.8 Issued
NCI E-192-2008-1-US-03 Improved Expression Of IL-12 Family Heterodimers US National Stage 12/992,077 8715964 Issued PDF
NHLBI E-254-2011-0-US-01 Critical Cysteine Oxidation Is Reduced During Ischemia-Reperfusion Injury Via S-nitrosothiol Formation And Identification Of The Myocardial S-nitrosothiol Proteome US 61/411,990 Abandoned
NIAID E-046-2010-2-PCT-01 Simian Adenoviral Vectors Based Vaccines PCT PCT COMB PCT/US2010/056004 Expired
NCATS E-211-2010-1-US-01 Methods of Treating Giardiasis US 61/411,509 Abandoned
NIAID E-189-2008-2-EG-05 LEISHMANIA VACCINE USING SAND FLY SALIVARY IMMUNOGEN EG National Stage 2010111894 Pending
NHLBI E-064-2014-0-US-01 Prior Enhanced Compressed Sensing (PRINCE-CS) Reconstruction For Dynamic 2D-Radial Cardiac MRI US 61/410,448 Abandoned
NIAID E-014-2011-0-US-01 Rapid Molecular Assays For Specific Detection and Quantitation Of Loa Loa Microfilaremia US 61/410,232 Abandoned
NIAID E-281-2010-0-US-01 Diagnostic Assays And Methods Of Use For Detection Of Filarial Infection US 61/410,239 Abandoned
NCATS E-256-2010-0-US-01 Alpha-Glucosidase Inhibitors And Methods of Their Use US 61/409,697 Abandoned
NCI E-065-2005-0-CA-07 NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS CA National Stage 2585091 Expired
NCI E-129-2008-0-US-03 Synthetic Analogs Of Juxtamembrane Domain Of IGF1R And Uses Thereof US National Stage 12/934,911 Abandoned
NIDDK E-140-2008-0-US-06 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists US National Stage 12/935,461 8735407 Issued PDF
NCI E-123-2008-0-US-03 Substituted IL-15 Polypeptides US National Stage 12/915,363 8415456 Issued PDF
NINDS E-225-2009-0-PCT-02 Compositions And Methods For The Treatment Or Prevention Of Mitochondrial Diseases PCT PCT PCT/US2010/054802 Expired
NCI E-227-2010-0-US-01 Methods of Treating Cancer And Other Diseases US 61/407,948 Abandoned
NHLBI E-183-2004-1-CA-03 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISORDERS CA National Stage 2589034 Expired
NCI E-132-2010-0-PCT-02 Methods Of Diagnosing And Prognosing Colonic Polyps PCT PCT PCT/AU2010/001432 Expired
NCI E-199-2010-0-US-01 Fluoroquinolone Derivatives As Inhibitors Of Tyrosyl-DNAphosphodiesterase (Tdp1) US 61/407,325 Abandoned
NCI E-191-2002-0-US-09 CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF. US CON 12/909,979 8278348 Expired PDF
NEI E-198-2008-0-PCT-02 Systemic Immunosuppression In The Treatment Of Age Related Macular Degeneration and Diabetic Retinopathy PCT PCT PCT/US2010/053734 Abandoned
NCI E-236-2010-0-US-01 ANTI-MAGE-A3-T Cell Receptors And Related Materials And Methods of Use US 61/405,668 Abandoned
NIAID E-301-2009-0-PCT-02 RSV Immunogens, Antibodies And Compositions Thereof PCT PCT PCT/US2010/053558 Expired
NCI E-118-2011-0-US-01 Devices And Methods For Mapping Nucleic Acids In Tissue US 61/405,502 Abandoned
NIAID E-018-2010-0-IN-06 RECOMBINANT MODIFIED VACCINIA ANKARA (MVA) VACCINIA VIRUS CONTAINING RESTRUCTURED INSERTION SITES IN National Stage 4311/DELNP/2012 Issued
NIAID E-018-2010-0-DE-11 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites DE EP 10771611.0 Issued
NIAID E-018-2010-0-DK-12 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites DK EP 10771611.0 Issued
NIAID E-018-2010-0-FR-13 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites FR EP 10771611.0 Issued
NIAID E-018-2010-0-NL-15 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites NL EP 10771611.0 Issued
NIAID E-018-2010-0-GB-14 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites GB EP 10771611.0 Issued
NIAID E-018-2010-0-EP-05 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites EP National Stage 10771611.0 Issued
NIAID E-018-2010-0-AU-03 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites AU National Stage 2010306559 Issued
NIAID E-018-2010-0-JP-07 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites JP National Stage 2012-534414 Issued
NIA E-051-2008-0-US-07 Compositions And Methods For Delivering Inhibitory Oligonucleotides US National Stage 12/988,148 8703921 Issued PDF
NIAID E-018-2010-0-ZA-09 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites ZA National Stage 2012/03551 Issued
NHGRI E-055-2005-2-US-04 Farnesyl Transferase Inhibitors (FTIs) For Treatment Of Laminopathies, Cellular Aging, And Artherosclerosis US DIV 12/905,838 8257915 Abandoned PDF
NIAID E-018-2010-0-PCT-02 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites PCT PCT PCT/US2010/052929 Expired
NIAID E-007-2010-1-PCT-01 Nucleic Acid Sequences Encoding Expandable HIV Mosaic Proteins PCT PCT COMB PCT/US2010/052916 Expired